Institutional investors hold a majority ownership of CELG through the 83.86% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2014, these large investors purchased a net $4.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 14.3 Million shares of Celgene
SWEDBANK ROBUR FONDER AB Bought 2.5 Million shares of Celgene
UBS GLOBAL ASSET MANAGEMENT (AME... Bought 2.2 Million shares of Celgene